The Nexus Group is a private equity firm managing several funds with offices in Massachusetts and South Carolina and affiliates in San Francisco, London, Munich, Geneva and Tokyo. The Group specializes in making private equity investments and in providing strategic assistance to medical technology and life science companies globally.
|EyeGate Pharmaceuticals||3/08||Series C||$15M||4|
|Presidio Pharmaceuticals||8/07||Series B||$26M||5|
|Cequent Pharmaceuticals||6/07||Series A||$9M||4|